The Infected Blood Compensation Scheme Regulations 2025
Draft 2025, ISBN 9780348268843
Draft Regulations laid before Parliament under section 79(10) of the Victims and Prisoners Act 2024, for approval by resolution of each House of Parliament.
Payment Scheme
Made ***
Coming into force 31st March 2025
The Minister for the Cabinet Office makes these Regulations in exercise of the powers conferred by sections 49(1), (2), (4) and (5), 50, 51, 52 and 79(1) of, and paragraphs 4(1) and (2) and 12(3) of Schedule 1 to, the Victims and Prisoners Act 2024f1.
In accordance with section 79(10) of the Victims and Prisoners Act 2024, a draft of this instrument was laid before Parliament and approved by a resolution of each House of Parliament.
Annotations to the whole text
Footnotes
- f1
-
2024 c. 21. See section 50(6) for the meaning of “specified”.
Contents
- Part 1: General
- 1Citation, commencement and extent
- 2Interpretation
- 3Meaning of “eligible infected person”
- 4Meaning of “eligible affected person”
- 5Meaning of “relevant person”
- 6Meaning of “deductible payment”
- 7Determining the “past amount” and “future amount” of certain awards
- 8Giving of notices and documents
- Part 2: Continuation and administration of the IBCS
- 9Continuation of the IBCS
- 10Eligibility criteria for appointment as a member of the IBCA
- 11Cessation of disqualification from eligibility for appointment to the IBCA
- 12Duties of the IBCA in relation to sums repaid to it
- Part 3: IBCS payments to eligible infected persons
- Chapter 1: Infected core payments
- 13Infected core payments: general
- 14Applications for infected core payments
- 15Amount of an infected core payment
- 16Injury (core) award
- 17Social impact (core) award
- 18Autonomy (core) award
- 19Basic financial loss award
- 20Additional financial loss (core) award
- 21Care (core) award
- 22Support scheme top-up (core) award
- Chapter 2: Infected supplemental payments
- General
- 23Infected supplemental payments: general
- 24Amount of an infected supplemental payment
- Infected supplemental award: unethical research practices
- 25Unethical research practices award
- 26Meaning of “unethical research practices”
- 27Amount of an unethical research practices award
- Infected supplemental award: severe health condition
- 28Severe health conditions
- 29Severe health condition award: general
- 30Amount of a severe health condition award
- 31Care (severe health condition) award
- 32Financial loss (severe health condition) award
- Infected supplemental award: exceptional loss
- 33Exceptional reduced earnings
- 34Excess past care costs
- 35Exceptional loss award: general
- 36Amount of an exceptional loss award
- 37Financial loss (PAYE earnings) award
- 38Financial loss (self-employment earnings) award
- 39Care (excess actual costs) award
- 40Care (excess deemed costs) award
- Chapter 3: Further infected payments
- Further infected core payments
- 41Further infected core payments: general
- 42Applications for further infected core payments
- 43Amount of a further infected core payment
- Further infected supplemental payments
- 44Further infected supplemental payments: general
- 45Applications for further infected supplemental payments
- 46Amount of a further infected supplemental payment
- Part 4: IBCS payments to eligible affected persons
- Chapter 1: Affected core payments
- General
- 47Affected core payments: general
- 48Applications for affected core payments
- Amount of an affected core payment
- 49Amount of an affected core payment
- 50Affected injury award
- 51Affected social impact award
- 52Affected autonomy award
- 53Affected financial loss award
- 54Past affected financial loss award
- 55Past affected financial loss award: overlapping awards
- Chapter 2: Affected supplemental payments
- 56Affected supplemental payments: general
- 57Eligibility for an affected supplemental payment
- 58Amount of the affected supplemental payment
- Part 5: Payment of support scheme payments by the IBCA
- Chapter 1: Introductory
- 59IBCA support scheme payments: general
- 60Amount, and payment, of an IBCA support scheme payment
- Chapter 2: Amount of a support scheme payment
- 61The support scheme winter fuel payment
- 62The IBSS amount: IBSS-registered infected persons
- 63The IBSS amount: IBSS-registered affected persons
- Part 6: Applications, determinations, reviews of determinations, and payments
- Chapter 1: Interpretation
- 64Interpretation of Part 6
- Chapter 2: Making an application
- 65Form and time of making an application
- 66General provisions on evidence
- 67Duty of relevant persons
- 68Amendment or withdrawal of an application
- 69Death before an application has been finally determined
- Chapter 3: Determination of applications
- 70Determination of applications by the IBCA
- 71Burden and standard of proof
- 72Requirement to give notice that no payment is to be made pursuant to an application
- 73Requirement to give notice of eligibility for an infected supplemental award
- Chapter 4: Offer and acceptance of an IBCS payment
- 74Requirement to offer to make an IBCS payment
- 75Acceptance of an offer to make an IBCS payment
- Chapter 5: Making and recovering IBCS payments
- 76Requirement to make an IBCS payment
- 77Making periodic payments
- 78Making an IBCS payment where an eligible person dies
- 79Payment of future financial loss and care awards where an infected SSP recipient dies
- 80Recovery of overpayments
- 81Offsetting
- Chapter 6: Reviews and appeals
- 82Review initiated by or on behalf of a person in respect of whom an application was made
- 83Review initiated by the IBCA
- 84Appeals
- Part 7: Miscellaneous
- 85Review of administration of the IBCS
- 86Revocation and savings
- 87Transitional provision
- Signature
- Schedule 1Infection severity levels for Hepatitis B and Hepatitis C
- Schedule 2: Severe health conditions
- 1Interpretation of Schedule 2
- 2Severe sight impairment
- 3Neurological conditions resulting in long-term severe physical disability
- 4Neurological conditions resulting in long-term severe neurocognitive impairment
- 5Severe psychiatric conditions
- 6End-stage kidney disease requiring renal replacement therapy
- 7Hepatitis-associated conditions resulting in long-term severe disability
- Explanatory note